Buy these dividend-paying real estate stocks ahead of earnings, says UBS

UBS says senior housing and skilled nursing REITs should see positive reads this summer, citing muted supply growth, demographic tailwinds, and near-90% Q2 occupancy (NIC MAP). The note is buy-rated on American Healthcare REIT, CareTrust REIT, Omega Healthcare Investors, and Welltower, with price targets implying ~11%–17% upside, including AHR raised to $63 (+17%) and Welltower to $271 (+17%). UBS also points to capital markets support—AHR raised ~$700mm equity to fund an awarded SHOP pipeline >$1bn—while maintaining 2026 core FFO expectations around consensus.

Analysis

The real opportunity here is not the aging-population story itself; it is the spread between private-market cap rates and public REIT funding costs. If that spread stays wide, WELL and AHR can compound by buying existing assets faster than they can be built, while CTRE benefits from being able to underwrite more situations than peers. The risk is that this is a capital-markets trade disguised as a fundamentals trade: if rates back up or credit spreads widen, accretion from acquisitions can vanish quickly even if occupancy stays high.

Winners are the platforms with the cheapest cost of capital and the best operating systems. WELL should outperform on any confirmatory earnings print because it can convert better operating data into multiple expansion, while AHR has more torque if equity-funded acquisitions close on schedule; both are 1-3 month catalysts into results and guidance. OHI is the more fragile name: its dividend screens attractive, but it is more exposed to operator credit and reimbursement/regulatory drift, so it can lag if investors decide to pay for growth quality rather than yield.

The contrarian view is that the market may already be pricing in the demographic tailwind but not the execution risk on new supply and integration. If development economics improve with lower rates, the current scarcity narrative weakens over 6-18 months as construction resumes and acquisition cap rates compress. Falsifiers: a meaningful uptick in senior-housing starts, weaker same-store NOI/FFO guidance in August earnings, or a sharp move higher in long rates that impairs accretion math.

Key Decisions for Investors

• Long WELL into the July 27 print; use any post-earnings dip as an add if same-store growth and transaction commentary stay constructive. Best risk/reward is if guidance improves while the stock remains anchored by low headline yield.
• Pair trade: long WELL / short OHI for 1-3 months. Thesis is quality of earnings and cost-of-capital advantage versus yield-seeking but more credit-sensitive cash flow; thesis breaks if OHI shows improving operator coverage and no reimbursement headwinds.
• Long AHR only on confirmation that the $1B+ pipeline converts at high-5% to low-6% yields without balance-sheet strain. This is a higher-beta acquisition story; if the Aug. 6 print shows slower deployment or weaker external growth, the stock can de-rate quickly.
• Maintain a tactical long CTRE versus broader REITs as a relative value expression on opportunistic underwriting, but keep size modest until early-August earnings verify that UK expansion is not diluting returns. Watch FX and funding costs as key falsifiers.
• If 10-year rates back up materially over the next 4-8 weeks, reduce exposure across the group and rotate toward the lowest-leverage names; acquisition-driven upside is most sensitive to cost of capital, not occupancy.